Publication
Article
BioPharm International
BioPharm International-03-15-2002Volume15 Issue 3
Inside Washington: Biotech Manufacturing ? Obstacle or Opportunity?
Author(s):
by Jill Wechsler, pp. 55-57, 60 The industry must ensure that manufacturing systems can produce high quality and consistent therapies, efforts that may lead to comparable "subsequent entry" products.
Articles in this issue
Inside Washington: Biotech Manufacturing ? Obstacle or Opportunity?
Guest Editorial: Warning Letters ? A Symptom?
The Importance of Freezing on Lyophilization Cycle Development
Outsourcing Outlook: Using Earned-Value Analysis for Better Project Management
Business Benefits of Computer Systems Validation
Validation of Quantitative PCR Assays?Addressing Virus Contamination Concerns
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Videos
Related Content
